Clinical Trial Update: HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating HRS-4642 in combination with nimotuzumab and chemotherapy as first-line treatment for advanced pancreatic cancer, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• HRS-4642
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Zhejiang University | Conditions: Metastatic Pancreatic Carcinoma | Phase 2 | Status: RECRUITING